Short Course Radiotherapy
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Study ID
- NCT07147179
- Status
- Recruiting
Conditions
- Central Nervous System Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 21 Years
- Healthy Volunteers
- Not accepted
Interventions
- Short Course Radiotherapy — RADIATIONParticipants will receive a shorter course of radiation therapy across 5 days (20 Gray in 5 fractions).
Study Details
This is a single arm prospective pilot trial determining the safety of short-course radiation therapy in pediatric patients with incurable central nervous system malignancies.
Key Dates
- Start date
- Apr 2, 2026
- Status verified
- Apr 2026
- Primary completion
- Mar 31, 2027
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 15 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Short Course RadiotherapyShort-course radiation therapy in pediatric patients with incurable central nervous system malignancies
Primary Outcome Measure
Safety of Short Course Radiotherapy [ Time Frame: 1 year ]
Central Contacts
- Kelly Clark267-854-5332
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Michael LaRiviere, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Philadelphia, PA
By research site
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- CNS Qualitative InterviewRecruiting · University of Colorado, Denver · Aurora, Colorado
- Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1PHASE2 · Recruiting · Washington University School of Medicine · St Louis, Missouri